Dr. Lal Pathlabs

₹3378.5 -27.4 | 0.8%

WEBSITE BSE:539524 NSE : LALPATHLAB 06 Sep, 16:03

Market Cap ₹28235 Cr.

Stock P/E 73.9

P/B 14.3

Current Price ₹3378.5

Book Value ₹ 235.9

Face Value 10

52W High ₹3457.6

Dividend Yield 0.71%

52W Low ₹ 1943.2

Edit Ratio

Dr. Lal Pathlabs Research see more...

EQUITY RESEARCH: DR LALPATHLABS

Overview Inc. Year: 1995Industry: Hospital & Healthcare Services

Dr. Lal PathLabs Ltd is an India-based organisation, that is engaged in offering diagnostic and associated healthcare assessments and offerings. It has a community that have a National Reference Laboratory in New Delhi, a Reference Laboratory in Kolkata and approximately 229 other clinical laboratories. The Company is engaged specially within the enterprise of strolling laboratories for carrying out pathological investigations of diverse branches of biochemistry, haematology, histopathology, microbiology, electrophoresis, immuno-chemistry, and different pathological and radiological investigations. The Company offers various tests by condition, which incorporates allergic reaction, diabetes, health checkups, viral infections, fever, heart sicknesses, high blood pressure, cancer, abortions, anaemia, arthritis, breast cancer, diphtheria, disease of liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular sickness and viral infections.

Dr. Lal Pathlabs Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Dr. Lal Pathlabs Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Dr. Lal Pathlabs Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Net Sales	541	637	765	882	1024	1165	1274	1491	1879	1769	1967
Other Income	9	17	22	28	32	46	58	51	53	47	60
Total Income	550	654	788	910	1056	1211	1331	1542	1932	1816	2027
Total Expenditure	406	487	564	652	768	882	946	1083	1366	1308	1408
Operating Profit	143	168	224	258	288	329	385	459	566	507	619
Interest	0	0	0	1	1	1	15	15	29	34	27
Depreciation	31	32	32	26	31	36	68	70	76	82	77
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	111	135	192	231	256	292	303	374	461	391	516
Provision for Tax	37	44	66	79	87	97	80	94	116	98	132
Profit After Tax	74	92	126	152	168	195	223	280	345	292	384
Adjustments	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	74	92	126	152	168	195	223	280	345	292	384
Adjusted Earnings Per Share	13.2	16	15.2	18.4	20.2	23.5	26.8	33.6	41.4	35.1	46

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	11%	10%	11%	14%
Operating Profit CAGR	22%	10%	13%	16%
PAT CAGR	32%	11%	15%	18%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	51%	-6%	22%	NA%
ROE Average	22%	23%	24%	28%
ROCE Average	28%	28%	30%	39%

Dr. Lal Pathlabs Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	216	319	479	586	777	931	1016	1217	1472	1690	1900
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	167	83	0
Other Non-Current Liabilities	1	-5	12	-6	-8	-20	68	77	91	82	53
Total Current Liabilities	95	110	89	83	111	134	211	252	451	432	424
Total Liabilities	312	424	580	663	879	1045	1296	1546	2181	2288	2377
Fixed Assets	114	119	130	121	173	173	297	300	371	361	309
Other Non-Current Assets	32	29	34	86	94	76	137	157	1110	1116	1147
Total Current Assets	166	276	416	456	613	796	862	1089	699	810	921
Total Assets	312	424	580	663	879	1045	1296	1546	2181	2288	2377

Dr. Lal Pathlabs Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	15	14	23	25	26	63	124	189	233	351	220
Cash Flow from Operating Activities	96	94	142	167	189	209	272	373	426	428	478
Cash Flow from Investing Activities	-86	-86	-148	-134	-166	-93	-19	-195	-449	-288	32
Cash Flow from Financing Activities	-10	1	1	-32	13	-54	-187	-136	141	-270	-404
Net Cash Inflow / Outflow	0	9	-5	1	36	61	65	42	118	-131	106
Closing Cash & Cash Equivalent	15	23	18	26	63	124	189	232	351	220	326

Dr. Lal Pathlabs Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	13.25	16.05	15.21	18.36	20.19	23.45	26.78	33.61	41.42	35.07	46.04
CEPS(Rs)	19.64	22.63	19.08	21.54	23.92	27.79	34.94	41.98	50.54	44.92	55.21
DPS(Rs)	1.1	1.53	2.45	3	4.5	6	12	20	12	12	24
Book NAV/Share(Rs)	35.24	53.56	57.88	69.57	91.03	108.32	117.99	141.25	169.74	195.74	221.45
Core EBITDA Margin(%)	24.83	23.57	26.36	26.09	25.01	24.28	25.74	27.33	27.28	26.04	28.43
EBIT Margin(%)	20.63	21.31	25.12	26.3	25.06	25.16	24.92	26.09	26.06	24.04	27.6
Pre Tax Margin(%)	20.59	21.25	25.05	26.22	24.98	25.1	23.77	25.09	24.54	22.09	26.23
PAT Margin (%)	13.68	14.41	16.43	17.29	16.43	16.78	17.52	18.79	18.38	16.53	19.54
Cash Profit Margin (%)	19.49	19.42	20.61	20.29	19.46	19.88	22.86	23.47	22.42	21.17	23.44
ROA(%)	26.82	24.94	25.04	24.53	21.82	20.31	19.07	19.71	18.53	13.09	16.48
ROE(%)	43.58	38.09	32.62	28.87	25.18	23.53	23.66	25.93	26.64	19.19	22.09
ROCE(%)	60.69	50.72	48.15	43.53	37.65	34.34	32.6	34.82	32.27	22.71	27.77
Receivable days	14.58	15.31	15.33	15.54	14.33	14.61	14.81	13.93	12.68	13.45	13.09
Inventory Days	6.38	7.09	6.63	6.46	7.8	8.53	11.87	11.5	7.65	6.52	4.72
Payable days	95.48	87.52	79.67	87.03	94.06	99.92	120.82	121.2	105.61	123.48	143.6
PER(x)	0	0	60.59	52.71	43.32	44.97	52.33	80.56	62.94	52.12	49.14
Price/Book(x)	0	0	15.92	13.91	9.61	9.73	11.88	19.17	15.36	9.34	10.22
Dividend Yield(%)	0	0	0.27	0.31	0.51	0.57	0.86	0.74	0.46	0.66	1.06
EV/Net Sales(x)	-0.04	-0.1	9.68	8.85	6.82	7.13	8.74	14.54	11.46	8.45	9.3
EV/Core EBITDA(x)	-0.16	-0.38	33.05	30.19	24.28	25.24	28.88	47.26	38.07	29.45	29.53
Net Sales Growth(%)	28.4	17.72	20.23	15.22	16.12	13.75	9.33	17.04	26.05	-5.84	11.18
EBIT Growth(%)	56.97	21.6	41.69	20.66	10.61	14.24	8.29	22.51	25.91	-13.16	27.66
PAT Growth(%)	51.31	24.08	37.04	21.26	10.35	16.15	14.19	25.51	23.26	-15.32	31.47
EPS Growth(%)	53.59	21.14	-5.23	20.69	10	16.13	14.19	25.51	23.26	-15.34	31.3
Debt/Equity(x)	0	0	0	0	0	0	0	0	0.24	0.15	0.05
Current Ratio(x)	1.74	2.5	4.68	5.52	5.51	5.92	4.08	4.32	1.55	1.87	2.17
Quick Ratio(x)	1.64	2.38	4.52	5.31	5.27	5.71	3.82	4.16	1.46	1.82	2.1
Interest Cover(x)	472.78	347.2	392.68	332.31	314.05	394.5	21.65	26.23	17.1	12.37	20.23
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0.02	0.02	0

Dr. Lal Pathlabs Shareholding Pattern

#	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoter	55.23	55.05	55.05	55.05	55.03	55.01	54.61	54.6	54.6	54.6
FII	23.44	22.37	23.26	25.8	24.89	23.27	24.36	25.35	26.15	25.42
DII	6.83	6.52	6.27	6.19	6.55	8.63	9.14	9.56	9.69	12.71
Public	14.5	16.06	15.43	12.96	13.52	13.1	11.89	10.49	9.56	7.26
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoter	4.6	4.59	4.59	4.59	4.59	4.59	4.56	4.56	4.56	4.56
FII	1.95	1.86	1.94	2.15	2.08	1.94	2.03	2.12	2.18	2.12
DII	0.57	0.54	0.52	0.52	0.55	0.72	0.76	0.8	0.81	1.06
Public	1.21	1.34	1.29	1.08	1.13	1.09	0.99	0.88	0.8	0.61
Others	0	0	0	0	0	0	0	0	0	0
Total	8.33	8.34	8.34	8.34	8.34	8.34	8.35	8.35	8.35	8.35

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 23%
Company has reduced debt.
Company is almost debt free.

Cons

Debtor days have increased from 123.48 to 143.6days.
Stock is trading at 14.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Dr. Lal Pathlabs News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Dr. Lal Pathlabs

Add Watchlist

Dr. Lal Pathlabs Research see more...

Overview Inc. Year: 1995Industry: Hospital & Healthcare Services

Dr. Lal Pathlabs Share Price

Alert Data

Quarterly Price

Peer Comparison

Dr. Lal Pathlabs Quarterly Results

Dr. Lal Pathlabs Profit & Loss

Growth Rates

Dr. Lal Pathlabs Balance Sheet

Dr. Lal Pathlabs Cash Flow

Dr. Lal Pathlabs Ratios

Dr. Lal Pathlabs Shareholding Pattern

Dr. Lal Pathlabs News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!